In a statement, the FDA's Dr. Binita Ashar said there are now 457 women in the US diagnosed with breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), up from 414 cases in the last report. The cancer has been linked to textured breast implants and it affects cells in the immune system.
Nine of them have died. As a supplement to its Wednesday statement, the FDA also published a letter asking health care providers to continue to report possible cases of breast cancer-related ALCL to the agency.More news: Ceferin re-elected unopposed as UEFA President
The FDA is meeting next month to review safety of all breast implants.
Women with breast implants have an increased risk of developing anaplastic large cell lymphoma, the FDA has said, compared to women who don't have breast implants. "Choosing to obtain a breast implant is a very personal decision that patients and their providers should make based on individual needs and with the most complete information about products", Ashar said.
"I know there are many choices of breast implants available to patients, including the size, implant fill and surface texture", Binita Ashar, who runs the Center for Devices and Radiological Health at the Food and Drug Administration, said in a news release.More news: Southampton should drop Jack Stephens against Cardiff due to Maya Yoshida return
Most of the cancer cases occurred in people who had textured surfaces on their implants, rather than smooth surfaces. "They are some of the first physicians to treat patients symptomatic for BIA ALCL and these patients are often missed and mistreated for mastitis, shingles and other conditions", said Michelle Forney, a California mother of two, diagnosed with ALCL past year. Smooth implants are softer than their textured counterparts, allowing for a more natural look and feel - but may lead to slightly visible rippling and shifting in position over time.
"When breast implants are placed in the body, they are inserted behind the breast tissue or under the chest muscle", the letter said.
A large manufacturer of breast implants, Allergan, suffered internationally in December when France issued a mandatory recall of textured breast implants, and shortly thereafter Allergan lost its CE mark. "Textured breast implants tend to stick to the body's tissue, helping them stay in the same position over time". In patients with breast implants, reported cases of BIA-ALCL were generally found adjacent to the implant itself and contained within the fibrous capsule.More news: 3rd T20I: Kiwis beat India by 4 runs to claim series